CIMT Endeavour

Event Details

Oslo Cancer Cluster will be presenting at this 3rd CIMT Endeavour Workshop on Translating cancer science into products and companies. The Endevaour workshop is a part of the annual CIMT Meeting, which is Europe’s largest immuno-oncology meeting.

The concept of CIMT Endeavour is to organize and build-up a unique and focused education and networking platform that addresses the translation of cancer immunotherapies from preclinical proof of concept to products for patients.

More information on CIMT Endevaour here.


07:30 – 08:00 Registration / Welcome Snack

08:00 – 08:10 Welcome
Dr. Björn-Philipp Kloke, CIMT

08:10 – 09:50 Session 1: From Science to Products – Change of Perspectives.
Chair: Dr. Harpreet Singh, immatics

CIMT-Scientist Presentation:
10 min + 25 min selected CIMT abstract speaker tbd
10 min + 25 min selected CIMT abstract speaker tbd

Expert Advice Panel: Discussion of abstracts

Dr. Ute Fink, Project Manager, Project Management Jülich
Dr. Thomas Hanke, Head of Immunology and Inflammation, Evotec
Michael Kring, Managing Director, High Tech Corporate Services GmbH
Dr. Ioannis Sapountzis, Global Head of Oncology Business Development
& Licensing, Boehringer Ingelheim GmbH
Dr. Rainer Wessel, Director, Ci3 Cluster

09:20 – 09:50 Coffee break

09:50 – 11:05 Session 2: Company Story/Successful Deals
Chair: Dr. Jutta Heix, Oslo Cancer Cluster
Dr. Claus Kremoser, Managing Director, Phenex Pharmaceuticals AG
Dr. Øyvind Arnesen, CEO, Ultimovacs AS
Prof. Dr. Dolores J. Schendel, CSO, Medigene AG

11:10 – 11:50 Session 3: Corporate View
Chair: Dr. Axel Hoos, GSK
40 min Keynote
Simeon George, Partner at SR One

11:50 – 12:00 Closing Words
Dr. Cedrik M. Britten, CIMT